Open AccessStathmin 1 expression predicts prognosis and benefits from adjuvant chemotherapy in patients with gallbladder carcinoma
Author(s) -
Xiaobo Bo,
Jie Wang,
Qiang Fu,
Yueqi Wang,
Houbao Liu,
Jiejie Xu
Publication year - 2017
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.19625
Subject(s) - medicine , stage (stratigraphy) , tissue microarray , stathmin , oncology , chemotherapy , immunohistochemistry , lymph node , survival analysis , pathology , biology , paleontology , biochemistry , phosphorylation
Abnormal expression of Stathmin 1(STMN1) plays an important role in the proliferation and migration of gallbladder carcinoma (GBC). The purpose of current study is to investigate the prognostic significance of STMN1 in GBC patients after surgery.